Clinical trial data for Ozempic (semaglutide for diabetes) indicate that 32.7% and 36.4% of patients using Ozempic experienced gastrointestinal side effects with weekly dosages of 0.5 mg and 1 mg, respectively, compared to 15.3% with placebo
Enhanced stability and potency for higher antioxidant defense against dark spots and UV damage
Firstly, while microneedle technology is more advanced in skin and ocular drug delivery, its application in liver disease treatment requires further research, which undoubtedly increases the complexity of clinical translation for liver diseases
This review by Oliver Philps provides an overview of GLP-1 agonists and where they fit in the treatment of diabetes, how the peptide drugs evolved over time to todays weight loss medications, and what to expect next
Beforehand, we tried having the patient wear an external catheter, but it did not fit him properly